A detailed history of Empirical Finance, LLC transactions in Viatris Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 38,919 shares of VTRS stock, worth $505,947. This represents 0.03% of its overall portfolio holdings.

Number of Shares
38,919
Previous 37,936 2.59%
Holding current value
$505,947
Previous $403,000 11.91%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$10.32 - $12.13 $10,144 - $11,923
983 Added 2.59%
38,919 $451,000
Q2 2024

Jul 30, 2024

SELL
$10.05 - $12.02 $5,155 - $6,166
-513 Reduced 1.33%
37,936 $403,000
Q1 2024

May 06, 2024

SELL
$11.27 - $13.53 $1,837 - $2,205
-163 Reduced 0.42%
38,449 $459,000
Q3 2023

Nov 02, 2023

BUY
$9.59 - $11.35 $43,433 - $51,404
4,529 Added 13.29%
38,612 $380,000
Q2 2023

Jul 27, 2023

BUY
$9.02 - $10.29 $37,658 - $42,960
4,175 Added 13.96%
34,083 $340,000
Q1 2023

Apr 05, 2023

BUY
$9.2 - $12.26 $16,698 - $22,251
1,815 Added 6.46%
29,908 $287,000
Q4 2022

Jan 24, 2023

BUY
$8.72 - $11.56 $22,018 - $29,189
2,525 Added 9.88%
28,093 $313,000
Q3 2022

Nov 04, 2022

BUY
$8.48 - $11.13 $40,432 - $53,067
4,768 Added 22.92%
25,568 $218,000
Q2 2022

Aug 01, 2022

BUY
$9.95 - $12.27 $13,094 - $16,147
1,316 Added 6.75%
20,800 $218,000
Q1 2022

Apr 21, 2022

BUY
$9.81 - $15.4 $46,734 - $73,365
4,764 Added 32.36%
19,484 $212,000
Q4 2021

Feb 04, 2022

BUY
$12.09 - $14.68 $41,335 - $50,190
3,419 Added 30.25%
14,720 $199,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $13,038 - $14,887
984 Added 9.54%
11,301 $153,000
Q2 2021

Aug 10, 2021

BUY
$12.97 - $16.15 $133,811 - $166,619
10,317 New
10,317 $147,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.